A Randomized comparison of a sirulimus-eluting stent with a standard stent for coronary revascularization
N. Engl. j. med
; 346(23): 1773-1780, 6 junho 2002.
Article
em En
| SES-SP, SESSP-IDPCPROD, SES-SP
| ID: biblio-1064865
Biblioteca responsável:
BR79.1
Localização: BR79.1
ABSTRACT
The need for repeated treatment of restenosis treated vessels remains the main limitation of percutaneous coronary revascularization. Because sirolimus (rapamycin) inhibits the proliferation of lymphocytes and smooth-muscle cells, we compared a sirolimus-eluting stent with a standard uncoated stents in patients with angina pectoris..
Buscar no Google
Coleção SES:
Producao_cientifica
Base de dados:
SES-SP
/
SESSP-IDPCPROD
Assunto principal:
Stents
/
Sirolimo
Tipo de estudo:
Clinical_trials
Idioma:
En
Ano de publicação:
2002
Tipo de documento:
Article